Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.56 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.47 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.44 |
| ▸ | PRKDC | P78527 | 9/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.39 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.35 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.35 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL125790 | 0.93 | ALOX5 (0.63) | ALOX5GGPS1PTGES2PRKDCAHR | |
| SCHEMBL17539833 | 0.91 | ALOX5 (0.58) | ALOX5GGPS1PTGES2PRKDCAHR | |
| SCHEMBL10122709 | 0.91 | ALOX5 (0.50) | ALOX5GGPS1PTGES2PRKDCAHR | |
| SCHEMBL10122461 | 0.91 | ALOX5 (0.46) | ALOX5GGPS1PTGES2PRKDCAHR | |
| SCHEMBL12011487 | 0.91 | ALOX5 (0.52) | ALOX5GGPS1PTGES2PRKDCAHR | |
| SCHEMBL20127422 | 0.90 | ALOX5 (0.57) | ALOX5GGPS1PTGES2PRKDCAHR | |
| SCHEMBL125803 | 0.90 | ALOX5 (0.57) | ALOX5GGPS1PTGES2PRKDCAHR | |
| SCHEMBL10122462 | 0.90 | ALOX5 (0.43) | ALOX5GGPS1PTGES2PRKDCAHR | |
| SCHEMBL15306303 | 0.90 | ALOX5 (0.60) | ALOX5GGPS1PTGES2PRKDCAHR | |
| SCHEMBL20127700 | 0.89 | ALOX5 (0.51) | ALOX5GGPS1PTGES2PRKDCAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180208836-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180208836-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | RER1, NR0B1, NR2E1 | ALOX5 4115/4885GGPS1 4058/4885PTGES2 4331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.